Changes in apoptosis of human polymorphonuclear granulocytes with aging

Area of Science:

• Immunology
• Cell Biology
• Gerontology

Background:

• Immune system function declines with age at cellular and organic levels.
• Apoptosis, or programmed cell death, is a critical process that may be altered in aging.
• Polymorphonuclear granulocytes (PMN) are key immune cells whose age-related apoptosis changes warrant investigation.

Purpose of the Study:

• To investigate the role of aging on PMN apoptosis under various stimulation conditions.
• To compare apoptosis rates in PMN from young and elderly healthy individuals.
• To determine if specific immune stimuli differentially affect PMN apoptosis in aging.

Main Methods:

• Isolated PMN from young (20-25 years) and elderly (65-85 years) subjects.
• Cultured PMN with and without various stimuli including PMA, H2O2, FMLP, GM-CSF, GSH, LPS, and IL-2.
• Assessed apoptosis using traditional staining, flow cytometry, and DNA gel electrophoresis.

Main Results:

• Unstimulated PMN showed slightly increased apoptosis with aging.
• PMA and H2O2 induced near-complete apoptosis in PMN from both age groups.
• GM-CSF, IL-2, and LPS significantly modulated apoptosis differently between young and elderly PMN, with only GM-CSF showing a slight effect in the elderly.

Conclusions:

• Aging alters PMN apoptosis, particularly its response to specific immune stimuli.
• Age-related changes in PMN apoptosis may contribute to increased susceptibility to infections, cancer, and autoimmune diseases in the elderly.
• Targeted modulation of PMN apoptosis could be a strategy to mitigate age-related immune decline.